[Drug (amiodarone)-induced thyroid disease].
Sato
Kanji
K
Department of Endocrinology, Tokyo Women's Medical University Institute of Clinical Endocrinology.
D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D020249:Hormone Replacement Therapy; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced* / Q000628:therapy; D010472:Perchlorates / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000145:classification / Q000628:therapy; D013974:Thyroxine / Q000627:therapeutic use
D010472:Perchlorates; D011239:Prednisolone; D000638:Amiodarone; D013974:Thyroxine; C494474:perchlorate